VNRX-7145-102: A Randomized, Drug-Drug Interaction Study to Assess the Safety and Pharmacokinetics (PK) of VNRX-7145 and VNRX-5024 (Ceftibuten) in Healthy Adult Volunteers
Latest Information Update: 13 Dec 2021
At a glance
- Drugs Ledaborbactam etzadroxil (Primary) ; VNRX-5024 (Primary)
- Indications Bacterial infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors VenatoRx Pharmaceuticals
Most Recent Events
- 08 Dec 2021 Status changed from recruiting to completed.
- 30 Sep 2021 Planned End Date changed from 1 Aug 2021 to 1 Nov 2021.
- 30 Sep 2021 Planned primary completion date changed from 1 Aug 2021 to 1 Nov 2021.